Is Rosacea a Bacterial Infection or Something Else?

Rosacea is not a bacterial infection, though bacteria do play a supporting role in the disease. It is a chronic inflammatory condition rooted in a dysfunctional immune response, abnormal blood vessel behavior, and a compromised skin barrier, with genetics loading the gun and environmental triggers pulling it. The reason for the confusion is understandable: antibiotics help treat it, and certain bacteria make it worse. But the relationship between rosacea and microbes is far more tangled than a simple infection, and understanding that distinction changes how you think about managing the condition.

Why Bacteria Got the Blame

For decades, the fact that antibiotics like tetracycline and doxycycline improved rosacea symptoms led many people, including some clinicians, to assume bacteria were the root cause. The logic seemed straightforward: if antibiotics fix it, bacteria must cause it. But low-dose doxycycline, the formulation now preferred for rosacea, works at doses too low to kill bacteria. Instead, it dampens inflammation directly by reducing certain enzymes that break down tissue and by dialing down inflammatory signaling molecules in the skin.¹ In lab studies, these low doses were actually more effective than high (bacteria-killing) doses at reducing key inflammatory markers.² The drug is working as an anti-inflammatory agent that happens to belong to the antibiotic family, not as an infection-fighter.

Demodex Mites and Their Bacterial Passengers

If rosacea is not a straightforward infection, microbes still matter. The most consistent microbial finding in rosacea research involves tiny mites called Demodex folliculorum that live in hair follicles. In one study, about 90 percent of rosacea patients had detectable Demodex mites on their facial skin, compared to roughly 12 percent of controls, and the average mite density in rosacea patients was more than twelve times higher.³ Another study confirmed that the highest concentrations of mites clustered on the cheeks, which also happens to be where rosacea is most prominent.⁴

The mites themselves are not the whole story. Living inside Demodex is a bacterium called Bacillus oleronius, and this organism appears to be a major instigator of inflammation. B. oleronius is not a normal resident of human skin. When the mites die and release these bacteria, the bacterial proteins provoke the immune system. In one study, about 80 percent of rosacea patients showed an immune reaction to specific proteins produced by B. oleronius, compared to 40 percent of healthy controls.⁵ A separate analysis found that B. oleronius triggers an inflammatory response in roughly three-quarters of rosacea patients.⁶ When neutrophils, one of the immune system’s first-responder cells, are exposed to B. oleronius proteins, they ramp up production of inflammatory cytokines and become more aggressive at migrating toward the perceived threat.⁷

This is why topical ivermectin, which the FDA approved for rosacea in 2014, works through a dual mechanism. It kills Demodex mites (antiparasitic action) and independently suppresses inflammatory pathways, including the same cathelicidin and enzyme pathways implicated in rosacea.⁸ The fact that the most effective treatments target both the mites and the inflammation tells you something about the disease: neither piece alone explains the whole picture.

An Immune System Running Too Hot

The deeper problem in rosacea skin is an immune system that overreacts to stimuli that healthy skin would shrug off. Researchers have found that rosacea skin produces abnormally high levels of a receptor called TLR2, which is part of the body’s early-warning system for detecting threats. TLR2 was specifically elevated in rosacea skin but not in other inflammatory skin conditions like eczema or psoriasis, making it something distinctive to this disease.⁹ The overexpression of TLR2 makes the skin hyper-responsive to a range of stimuli, essentially lowering the threshold for an inflammatory flare.¹⁰

Downstream of TLR2, rosacea involves an unusual form of a natural antimicrobial peptide called cathelicidin. In healthy skin, cathelicidin helps fight infection. In rosacea, an enzyme called KLK5 processes cathelicidin into an abnormal fragment called LL-37, which instead of fighting germs triggers blood vessel growth, recruits immune cells, and causes redness. Treatment with azelaic acid gel has been shown to reduce both KLK5 and cathelicidin levels in rosacea skin over several weeks.¹¹ The central takeaway is that rosacea skin is not fighting off a particular invader. It is misfiring its own defense systems.

The Blood Vessel Problem

Flushing and persistent redness are the hallmarks most people associate with rosacea, and these come from abnormal blood vessel behavior. Skin biopsies from rosacea patients show increased expression of VEGF, a growth factor that promotes the formation of new blood vessels, in affected areas compared to unaffected skin on the same person.¹² The immune cells that infiltrate rosacea skin also express VEGF and its receptors at high rates, linking the inflammatory and vascular components of the disease directly.¹³

Nerve endings in the skin contribute as well. Sensory receptors called TRPV1 and TRPA1, which respond to heat, cold, spicy compounds, and certain chemicals, are thought to play a role in rosacea flares. These receptors sit on both nerve endings and skin cells, and when activated they promote the release of substances that dilate blood vessels and drive inflammation.¹⁴ This explains why the classic rosacea triggers, including hot drinks, spicy food, temperature extremes, and emotional stress, all activate these same receptor pathways.

The Gut Connection

One of the more surprising lines of research links rosacea to conditions in the gut. Small intestinal bacterial overgrowth (SIBO), where too many bacteria colonize the small intestine, shows up in roughly half of rosacea patients, a rate significantly higher than in healthy controls.¹⁵ In one clinical trial, treating SIBO with antibiotics led to clearing or major improvement of skin symptoms in most patients who tested positive, while those given placebo stayed the same or worsened.¹⁶ SIBO appears to be more strongly associated with the bumpy, pimple-like subtype of rosacea (papulopustular) than with the redness-dominant subtype.¹⁵

The other gut microbe that comes up repeatedly is Helicobacter pylori, the stomach bacterium linked to ulcers. A review concluded that H. pylori infection is involved in rosacea development and recommended testing rosacea patients for it.¹⁷ However, a separate meta-analysis of seven studies found that eradicating H. pylori did not produce a statistically significant improvement in rosacea symptoms.¹⁸ The association exists, but whether treating H. pylori actually helps rosacea remains genuinely unclear. This is a case where enthusiasm has outrun the evidence.

Genetics Set the Stage

A large genome-wide study of over 73,000 people of European ancestry identified seven gene regions linked to rosacea severity. Several of these genes are involved in immune regulation, including one in the HLA region (which governs how the immune system distinguishes self from foreign) and the IL13 gene, which is involved in allergic and inflammatory responses. Interestingly, other identified genes, like IRF4, HERC2-OCA2, and SLC45A2, are better known for their role in skin pigmentation.¹⁹ This genetic overlap with pigmentation genes helps explain the well-known clinical observation that rosacea is far more common in people with lighter skin. It is not simply that redness is easier to see on fair skin; the genetic architecture of lighter pigmentation appears to overlap with susceptibility to the disease itself.

Separate research using whole genome sequencing in rosacea families identified rare variants in genes related to neurogenic inflammation, the process by which nerve signals drive inflammatory responses in tissue.²⁰ Together, these findings paint a picture of genetic predisposition operating across multiple systems: immune function, nerve-driven inflammation, and skin pigmentation.

Skin Barrier Breakdown and the Vicious Cycle

Rosacea skin loses water faster than healthy skin, has a higher pH, and is chronically drier.²¹ The underlying inflammation accelerates the turnover of skin cells, but the rapidly produced replacement cells do not form a barrier that works properly. This defective barrier lets more water escape, which itself becomes another trigger for inflammation, creating a self-perpetuating loop.²² This is part of why gentle skincare and barrier-repair moisturizers are not just cosmetic advice for rosacea patients; they address a measurable dysfunction in the skin.

UV radiation worsens this cycle. It generates reactive oxygen species in the skin, and rosacea patients already have higher baseline levels of these damaging molecules than healthy controls.²³ Daily broad-spectrum sunscreen is one of the few interventions that virtually every dermatologist agrees on for rosacea, regardless of subtype.

Food and Drink Triggers

Diet does not cause rosacea, but certain foods reliably provoke flares in susceptible people. The most commonly reported dietary triggers include alcohol, spicy foods, hot beverages, and foods containing cinnamaldehyde, the compound found in cinnamon, tomatoes, citrus, and chocolate. Histamine-rich foods like aged cheese, wine, and processed meats are also frequently implicated.²⁴ These triggers connect back to the vascular and nerve pathways described above. Alcohol, for instance, directly promotes flushing, and capsaicin in spicy food activates TRPV1 receptors. A trigger diary remains one of the most practical tools for rosacea management because the specific culprits vary considerably from person to person.

How the Skin Microbiome Differs Between Subtypes

Rosacea is not one disease but at least two distinct subtypes, and the microbial communities on the skin reflect this. Research has shown that the bacterial populations on the facial skin differ between the redness-dominant subtype (erythematotelangiectatic) and the bumpy subtype (papulopustular). In papulopustular rosacea, for example, certain bacterial groups like Proteobacteria and Firmicutes are overrepresented, while Actinomycetes, which dominate in the redness subtype, are relatively scarce.²⁵ Whether these shifts in microbial community are a cause or a consequence of the disease process remains an open question. The altered skin environment, with its higher pH and compromised barrier, could be creating conditions that favor certain microbes over others rather than the other way around.

When Rosacea Affects the Eyes

Up to half of rosacea patients develop eye symptoms, a form of the disease called ocular rosacea that many people do not connect to their skin condition. It manifests as gritty, burning eyes, redness along the eyelid margins, and sometimes blurred vision. Research has documented measurable loss of meibomian gland tissue, the tiny glands along the eyelids that produce the oily component of tears, in rosacea patients.²⁶ Ocular symptoms can actually precede any visible skin changes, making the diagnosis easy to miss if you are not looking for it.²⁷ Intense pulsed light treatment has shown promise for improving eyelid parameters and ocular symptoms in rosacea-associated meibomian gland dysfunction over the long term.²⁸

Stress, Nerves, and the Feedback Loop

Emotional stress is reported as a trigger by a large majority of rosacea patients, but the relationship goes beyond simply “stress makes you flush.” Mast cells, which are immune cells packed with histamine and other inflammatory chemicals, sit at the intersection of the nervous and immune systems in rosacea skin. Nerve signals from stress trigger mast cells to release histamine and inflammatory mediators, which cause flushing, burning, and itching. Histamine then stimulates the nerve endings to release more signaling molecules, creating a bidirectional feedback loop between nerves and immune cells.²⁹ Emotional stress also activates the body’s broader stress-hormone axis, which releases inflammatory factors that impair skin barrier function.³⁰ This nerve-immune crosstalk is one reason why rosacea is sometimes described as a neuro-inflammatory disease rather than a purely skin-level problem.

A Uniquely Human Anatomy

One recent and admittedly speculative hypothesis proposes that rosacea may partly be an evolutionary trade-off linked to a feature unique to human faces: the buccal fat pad, the deep pad of fat in the cheeks. The “Cheeky Ape Hypothesis” suggests that this fat pad compresses the facial vein and its branches, impairing blood drainage and creating conditions that contribute to chronic inflammation in the central face.³¹ It is worth noting that this has been published as a hypothesis paper, not a confirmed finding, and it would need substantial anatomical and clinical testing. But the idea is interesting because rosacea does not occur in other primates, and its characteristic distribution on the central face does overlap with the drainage territory of the facial vein. Whether or not the hypothesis holds up, it highlights something important: rosacea is a distinctly human condition, and we still do not fully understand why.